It seems pretty obvious that Starpharma have decided to treat this initially as a soft launch for Viraleze via the Lloyds pharmacy website. While we don't know the exact reasons for this, I think that we need to trust that this decision has been made for a reason. Who knows, maybe it is to appeal to the early adopters and let word of mouth build demand while production is ramped up for the full on launch into 14 000 more retail outlets in the coming weeks.
Putting aside the snide comments from holders here at times, I feel we should try to rein in some of the enthusiasm here for a sudden hard launch and just see what the next 2 weeks bring. We should try to have a little faith that maybe Starpharma do have a plan. Covid-19 isn't going anywhere in a hurry.
SPL Price at posting:
$2.08 Sentiment: Buy Disclosure: Held
